MET and glioma: Further experiments reveal that the addition of a Wnt/β‐catenin activator (CHIR99021) induces the expression of β‐catenin and Met and increases the proliferative and invasive capacities of control medium‐treated glioma cells but not those of hNSC‐CM‐treated glioma cells.